Journal of Bioanalysis & Biomedicine

17^th European Biosimilars Congress

April 04-05, 2024 | Madrid, Spain

Scientific Tracks Abstracts

• Innovations in biosimilars: Ensuring quality from a regulatory angle

  Luis Gerardo Alcala Carmona

  PDF HTML

• Optimizing soluble expression of an anti-VEGF biosimilar to Brolucizumab for the treatment of age-related macular degeneration

  Mohadeseh Haji Abdolvahab

  PDF HTML

• Towards human fabrics: Ethical and regulatory issues

  Elena Salvaterra

  PDF HTML

• Trastuzumab biosimilar (Kanjinti) efficacy in breast cancer: Case report in Saudi Arabia

  Mohamed Abdel Raof Elsisi and Sara Essam Bauomy

  PDF HTML

• What is the real value of phase three trials in biosimilars assessment?

  Francois Xavier Frapaise

  PDF HTML